Deca 200 / NPP 150 by Dragon Pharma

Dragon Pharma Original Formula

Nandrolone Dual-Ester Blend

Deca/NPP Blend350 mg/ml
Composition Deca 200 + NPP 150
Release Fast + Sustained
Anabolic Ratio 125
Androgenic Ratio 37
Carrier MCT Oil
Form Injection, 10ml
Availability: In Stock
$126.00
Quantity
Shipping
Wishlist

Nandrolone Dual-Ester Blend — Deca 200 / NPP 150 by Dragon Pharma

The Deca/NPP Blend is Dragon Pharma's formulation of two Nandrolone esters in a single 350mg/ml vial — Nandrolone Decanoate at 200mg/ml and Nandrolone Phenylpropionate at 150mg/ml. Unlike blends that combine different active compounds, this product combines two esters of the same molecule to engineer a specific release profile: NPP's faster onset layered beneath Deca's prolonged sustained release.

Also searched as: Deca NPP blend, Nandrolone dual ester, Deca 200 NPP 150 Dragon Pharma, Nandrolone blend 350mg.

Why Two Esters of the Same Compound — The Release Engineering Logic

This blend is unique in the Dragon Pharma range — two esters of identical active compound combined to produce a release profile neither ester achieves alone. This is the Nandrolone equivalent of the multi-ester testosterone logic in Sustanon:

Component Amount Half-Life Role in Blend
Nandrolone Phenylpropionate (NPP) 150 mg/ml ~5 days Faster onset — blood levels build within the first week; earlier joint comfort and anabolic effects
Nandrolone Decanoate (Deca) 200 mg/ml ~15 days Sustained baseline — maintains elevated Nandrolone levels throughout the full cycle with less frequent contribution from the short ester

The combined result: within the first 1-2 weeks, the NPP component produces a meaningful Nandrolone blood level while the Deca component is still building. By weeks 4-6, the Deca component has reached steady-state and becomes the dominant contributor. The blend therefore avoids the primary criticism of standalone Deca — that a 14-16 week cycle is required before full steady-state is achieved — while retaining Deca's sustained, stable long-term levels.

Quantified Onset Comparison

Protocol Meaningful blood levels by week... Steady-state by week... PCT start post-cycle
Standalone Deca only (~15 day t½) Week 3–4 Week 10–12 3–4 weeks post
Standalone NPP only (~5 day t½) Week 1–2 Week 3–4 10–14 days post
Deca/NPP Blend (this product) Week 1–2 (NPP component) Week 8–10 (Deca component) 3–4 weeks post (Deca-governed)

Important: PCT timing is governed by the longest ester present — the Deca component's ~15-day half-life means PCT cannot begin until 3-4 weeks after the last injection, the same as standalone Deca. The NPP component clears sooner, but the Deca component's ongoing suppression means waiting for it to clear before PCT can be effective.

Effects and Benefits

  • Faster initial onset than standalone Deca — NPP component produces meaningful Nandrolone levels within the first 2 weeks
  • Sustained, stable Nandrolone levels across the full cycle from the Deca component
  • Joint comfort benefits from Nandrolone's collagen synthesis effects — present earlier than with standalone Deca due to NPP onset
  • Lean mass gains with lower water retention than testosterone at equivalent doses
  • High concentration (350mg/ml) reduces injection volume for the combined Nandrolone load

Dosage and Administration

Experience Level Weekly Dose Frequency Cycle Length
Intermediate 350–525 mg/week (1–1.5ml) Twice weekly 12–16 weeks
Advanced 525–700 mg/week (1.5–2ml) Twice weekly 12–16 weeks

Twice-weekly injection provides stable combined blood levels — the NPP component's ~5-day half-life benefits from twice-weekly dosing, while the Deca component is stable on once or twice weekly. Splitting the weekly dose into two injections maintains tighter levels from both components simultaneously. At 350mg/ml, a 1ml twice-weekly injection delivers 700mg/week total Nandrolone (400mg Deca + 300mg NPP).

Side Effects

  • Elevated prolactin from 19-nor activity — Cabergoline is commonly used; prolactin-related effects ("Deca dick") onset earlier than standalone Deca due to NPP component
  • Suppression of natural testosterone — Post Cycle Therapy required; PCT timing governed by Deca ester — start 3-4 weeks after last injection
  • Lower aromatisation than testosterone — estrogen management less critical, but possible at higher doses; Arimidex available if needed
  • Very long detection window — Nandrolone metabolites detectable up to 18 months after last injection regardless of which ester was used

Deca/NPP Blend vs Standalone Products

  • Deca/NPP Blend (this product) — faster onset than standalone Deca; sustained levels from the Decanoate component; one vial; twice-weekly injection
  • Deca 300 (standalone) — simpler single-ester, predictable pharmacokinetics; weekly injection sufficient; for users not concerned about onset speed
  • NPP 150 (standalone) — fastest Nandrolone onset; EOD injection required; suitable for shorter cycles where the Deca ester's slow build is a disadvantage

Building a Cycle Around the Deca/NPP Blend

  • Enantat 250 or Cypionat 250 as the testosterone base — Nandrolone is not run alone
  • Dianabol 20 as a short oral kickstart during the first weeks — the NPP component accelerates Nandrolone onset but a Dianabol kickstart still bridges the gap while both esters build
  • Cabergoline for prolactin management throughout
  • Clomid or Nolvadex for Post Cycle Therapy

"The Deca/NPP Blend combines two esters of the same Nandrolone molecule to produce a release profile neither ester achieves alone — the faster onset of NPP layered beneath the sustained, stable baseline of Deca, in a single high-concentration vial."

Storage and Handling

Store at room temperature away from direct sunlight and heat. Use sterile technique for every draw — a fresh needle for drawing and a separate needle for injection is recommended.

Please log in to write review.

Each ester releases Nandrolone at a different rate — NPP (~5-day half-life) builds blood levels quickly in the first 1-2 weeks, while Deca (~15-day half-life) builds more slowly but maintains stable levels throughout a long cycle. Combining them produces faster initial onset than standalone Deca while retaining Deca's sustained, stable long-term release — a profile neither ester achieves alone.

It significantly reduces the benefit gap — the NPP component produces meaningful Nandrolone blood levels within 1-2 weeks, much sooner than standalone Deca's 3-4 week onset. However, a Dianabol kickstart still provides a different anabolic mechanism and additional early mass stimulus beyond what the NPP component alone provides.

PCT timing is governed by the longest ester — Nandrolone Decanoate's ~15-day half-life means 3-4 weeks after the last injection, identical to standalone Deca. Despite the NPP component clearing faster, the Deca component continues suppressing the HPG axis until it too has cleared sufficiently.

Twice weekly — this frequency maintains stable levels from both ester components. The NPP portion (~5-day half-life) benefits more from twice-weekly dosing than the Deca portion would alone, while still allowing the Deca component sufficient accumulation time between doses.

Nandrolone metabolites (primarily 19-norandrosterone) remain detectable by WADA-accredited testing for up to 18 months regardless of whether Decanoate or Phenylpropionate ester was used — the metabolite is the same. This is among the longest detection windows of any AAS and is relevant for any tested athlete.

At $126 per 10ml vial at 350mg/ml, the blend offers 3,500mg total Nandrolone — combining what would otherwise require two separate vials. The convenience of a single vial, single injection covering both esters, and the engineered dual-release profile represents the value beyond simply combining two separate products.

Related Products